Sickle Cell Disease (SCD)
SorsaMED promotes socially equitable treatment options for SCD sufferers through innovative biomedical technologies.
We are creating products that
present an alternative to opioids.
By combining the untapped benefits of algae and cannabinoids, we are creating products that present an alternative to opioids.
Our emphasis is on developing pain and crisis treatment options that effectively address chronic pain, provide nutritional supplements and help with mood stabilization for marginalized communities.
The Three Cornerstones of SorsaMED Solutions
A cycle of chronic inflammation, acute pain, fatigue, and shortness of breath occur repeatedly throughout the life of sickle cell patients. Recurrent episodes of severe pain happen from childhood into adulthood and cause progressive damage to organs, including the brain, kidneys, lungs, bones, and cardiovascular system. This leads to a shortened life expectancy, with an average of 42 years for males and 48 years for females in the U.S.
SorsaMED’s Approach: Our emphasis is on the development of products that improve blood flow, thus reduce inflammation and ultimately pain for SCD patients.
By tapping into the benefits of algae, we are discovering the ways in which the plant can sustain and support human metabolic processes. Individuals with Sickle Cell Anemia frequently have problems with the absorption of nutrition into their bloodstream, this means they must consume nutrient-rich foods that oxidize their blood. Currently, approved sickle cell treatment options are addictive and do not address the nutritional deficits caused
SorsaMED’s Approach: Our team is focusing on the development of products that simultaneously supplement lost nutrients and provide viable alternatives to opioids for pain management.
By introducing the mood stabilization properties of cannabinoids and combining those with high nutrient algae, we promote the development of solutions that address depressive symptoms and negative moods reported by sickle cell patients. SCD sufferers both young and adult, frequently report feelings of sadness and isolation. While cultural norms can greatly impact the level of support sickle cell sufferers receive from their community, even those who receive support can still suffer from negative thoughts and moods.
SorsaMED’s Approach: Our products will prioritize the reduction of anxiety, the control of nausea and vomiting, and the overall improvement of the mood and quality of life for those managing their Sickle Cell Anemia.